Amardeep Heer

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

P. Kalra, D. McAuley, G. Glenn, 2021, The New England journal of medicine.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, Shruti Singh, 2020, The Lancet.

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.351 Variant

D. Moodley, S. Madhi, V. Shinde, 2021, The New England journal of medicine.

Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

Adam C. Champion, Jane E. Ewing, M. Elnaggar, 2021, The Lancet Respiratory Medicine.

Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial

J. Bradley, P. Kalra, G. Glenn, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Respiratory Syncytial Virus Disease Burden in Community-Dwelling and Long-Term Care Facility Older Adults in Europe and the United States: A Prospective Study

J. Pirçon, Rajul Patel, I. Leroux-Roels, 2023, Open forum infectious diseases.

Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial

H. Randeva, P. Kalra, M. Boffito, 2022, The Lancet Infectious Diseases.

Evaluating the clinical effectiveness of the NHS Health Check programme: a prospective analysis in the Genetics and Vascular Health Check (GENVASC) study

K. Khunti, N. Samani, A. Zafar, 2023, BMJ Open.

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B.1.1.7 Variant

P. Kalra, D. McAuley, G. Glenn, 2021, medRxiv.

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial

F. Markowetz, T. Bray, L. Lovat, 2020, The Lancet.